-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Tenet Healthcare, Raises Price Target to $230

Benzinga·11/13/2025 18:58:54
Listen to the news
JP Morgan analyst Benjamin Rossi maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $200 to $230.